Company profile: The Oncology Institute
1.1 - Company Overview
Company description
- Provider of oncology and hematology care, offering treatment for a wide range of cancers (including breast, lung, prostate) and blood disorders (anemia, leukemia, thrombocytopenia), access to clinical trials, and diagnostic laboratory services such as CBC, reticulocyte count, special tests of blood cell function, and other specialized blood tests for uncommon disorders.
Products and services
- Blood Disorders Treatment: Hematology-focused care that manages anemia, leukemia, and thrombocytopenia, delivering professional support for individuals with hematological malignancy and related blood disorders
- Cancer Treatment: Clinical-grade care for a wide range of cancers, including breast, lung, and prostate, supplying professional support for those affected by cancer
- Clinical Trials: Investigational participation in clinical trials for new cancer treatments, enabling patients to join studies of new therapies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to The Oncology Institute
LASIK MD
HQ: Canada
Website
- Description: Provider of medical solutions; detailed product and service information is not available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LASIK MD company profile →
US HealthVest
HQ: United States
Website
- Description: Provider of behavioral health services and development support for psychiatric hospitals, offering inpatient psychiatric care, substance abuse treatment, partial hospitalization (PHP), intensive outpatient programming (IOP), telehealth services, and 24/7 no-cost mental health and addiction crisis assessments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US HealthVest company profile →
ShorePoint Health Charlotte
HQ: United States
Website
- Description: Provider of joint commission accredited full-service hospital care, offering a wide range of care services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ShorePoint Health Charlotte company profile →
Cancer Treatment Centers
HQ: United States
Website
- Description: Provider of personalized cancer care, offering multidisciplinary treatment plans (surgery, chemotherapy, radiation, targeted therapy), supportive care to manage side effects and provide emotional/spiritual support, telehealth consultations and follow-ups, a physician directory, specialized pancreatic cancer treatments, and GI Cancer Centers including nutrition therapy and clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cancer Treatment Centers company profile →
Ramsay Santé
HQ: France
Website
- Description: Provider of hospital care and clinic-based services across medicine, surgery, obstetrics, follow-up care (cancer treatment and radiation therapy, alcoholism and obesity treatment), psychiatry, and rehabilitation, as France’s Ramsay Générale de Santé—the No. 1 European private hospitalization group.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ramsay Santé company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for The Oncology Institute
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to The Oncology Institute
2.2 - Growth funds investing in similar companies to The Oncology Institute
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for The Oncology Institute
4.2 - Public trading comparable groups for The Oncology Institute
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →